Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres-Reference-Cited by-同舟云学术

Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres

Published:2016-08-10 Issue:3 Volume:8 Page:196-202
ISSN:2041-4137
Container-title:Frontline Gastroenterology
language:en
Short-container-title:Frontline Gastroenterol

Author:

Samaan Mark A,Pavlidis Polychronis,Johnston Emma,Warner Ben,Digby-Bell Jonathan,Koumoutsos Ioannis,Fong Steven,Goldberg Rimma,Patel Kamal,Gulati Shraddha,Medcalf Lucy,Sastrillo Marlene,Brown-Clarke Cordella,Bidewell-Sullivan Johanna,Forsyth Katrina,Lee Emma,Stanton Anna,Duncan Julie,Chung-Faye Guy,Dubois Patrick,Powell Nick,Anderson Simon,Sanderson Jeremy,Hayee Bu'Hussain,Irving Peter M

Publisher

BMJ

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. Inflammatory bowel disease: epidemiology and management in an English general practice population;Rubin;Aliment Pharmacol Ther,2000

2. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review;Fraser;Gut,2002

3. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial;Colombel;Gastroenterology,2007

4. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

5. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute interstitial nephritis in patients with inflammatory bowel disease treated with vedolizumab: a systematic review;Scandinavian Journal of Gastroenterology;2024-04-29

2. Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational study;Advances in Clinical and Experimental Medicine;2023-05-11

3. A review article of inflammatory bowel disease treatment and pharmacogenomics;Beni-Suef University Journal of Basic and Applied Sciences;2023-03-30

4. Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies;Journal of Crohn's and Colitis;2023-03-13

5. Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study;Expert Opinion on Biological Therapy;2023-03-02